Search Results: SFRS2 / non-coding


Search Results

EDRN Biomarkers:
Loading...
FDA Biomarkers:
Loading...
Disease Mutations:
Loading...
Differential Expression:
Loading...
Healthy Expression:
Loading...
Mutation Literature Mining:
Loading...
Expression Literature Mining:
Loading...
Reactome:
Loading...


Overview search results for:

Gene: SFRS2 / non-coding

Gene specific overview of data in OncoMX.
Access to gene specific results, please scroll to the bottom of this page.

Additional Resources: HemOnc, EDRN, UniProt, iPTMnet, NCBI

Differential expression of various cancer types

Frequency of expression for each cancer type where blue denotes up regulation and orange down regulation.

Human Normal Bulk RNA-seq Expression Overview

Expression
Low expression
Medium expression
High expression
Healthy bulk RNA-seq for human tissue and the level at which genes are expressed. The silver dots denote absent expression levels, blue denotes low expression, green denotes medium expression and red high expression.

Mouse Normal Bulk RNA-seq Expression Overview

Absent
Low Exp Lvl
Medium Exp Lvl
High Exp Lvl
Healthy bulk RNA-seq for mouse tissue and the level at which genes are expressed. The silver dots denote absent expression levels, blue denotes low expression, green denotes medium expression and red high expression.

Mutation Frequencies by Cancer Type

Mutation frequencies by cancer types

Expression Literature mining across different cancers

Expression literature evidence for the specific gene across different cancers

Mutation Literature mining across different cancers

Mutation literature evidence for the specific gene across different cancer types

Details for search:

Gene: SFRS2 / non-coding

Biomarker Details



FDA approved biomarker information

Disease Use Trade Name Manufacturer Submission Is Panel Gene Symbol UniProtKB/SwissProt AC Biomarker ID Created Biomarker Origin NCIT Biomarker Disease DOID Histological Type Approved Indication Actual Use Speciment Type Method Number Genes Adoption Evidence Clinical Trial ID Regulatory Approval Status Phase PMID Study Design Clinical Significance Drug Description Notes

Reactome pathways associated with gene

UniProtKB/SwissProt AC Pathway ID URL Event Evidence Code Species

Mutation Details

UniProtKB/SwissProt AC3 Gene Symbol RefSeq AC Genome Position Nuc. Position Ref. Nuc. Var. Nuc. AA Position Ref. AA Var. AA Polyphen2 PMID Cancer Type Source Functional Impact Status Anatomical Entity ID

Expression Details

UniProtKB/SwissProt AC Gene Symbol Log2 F.C. P-value Adj. P-value Significant Expression Trend TCGA Study Cancer Type Patient Freq. Source PMID Anatomical Entity ID

Bgee Details

Ensemble gene ID Gene Symbol Anatomical Entity ID Anatomical Entity Name Developmental Stage ID Developmental Stage Name Expression Lvl - Gene Expression Lvl - Anatomical Call Quality Expression Score